(Q43777307)

26 November 2017

title

Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009? (English)

1 reference

26 November 2017

0 references

1 reference

3

1 reference

26 November 2017

Cristina Giambi

6

0 references

Fortunato D'Ancona

object named as

Fortunato D'Ancona

4

0 references

Stefania Salmaso

9

object named as

Stefania Salmaso

1 reference

26 November 2017

Jolita Mereckiene

1

1 reference

26 November 2017

Suzanne Cotter

2

1 reference

26 November 2017

Daniel Levy-Bruhl

5

1 reference

26 November 2017

Kari Johansen

7

1 reference

26 November 2017

Luca Dematte

8

1 reference

26 November 2017

Pawel Stefanoff

10

1 reference

26 November 2017

Darina O'Flanagan

11

1 reference

26 November 2017

language of work or name

English

0 references

publication date

6 May 2010

1 reference

26 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

26 November 2017

volume

28

1 reference

26 November 2017

issue

28

1 reference

26 November 2017

page(s)

4470-4477

1 reference

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.037

Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.037

Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.037

A success story: universal vaccination in Italy--what has to be done to eradicate residual acute hepatitis B?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.037

Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.037

Epidemiologic methods in immunization programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.037

The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.037

Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.037

The global impact of vaccination against hepatitis B: a historical overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.037

Hepatitis B vaccination in travelers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.037

Hepatitis B immunisation in travellers: poor risk perception and inadequate protection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.037

10.1016/J.VACCINE.2010.04.037

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference